GLP-1 Receptor Agonists and Diabetic Kidney Disease: A Call of Attention to Nephrologists

GLP-1 Receptor Agonists and Diabetic Kidney Disease: A Call of Attention to Nephrologists

Type 2 diabetes mellitus (T2DM) represents the main cause of chronic kidney disease (CKD) and end-stage renal disease (ESKD), and diabetic kidney disease (DKD) is a major cause of morbidity and mortality in diabetes. Despite advances in the nephroprotective treatment of T2DM, DKD remains the most co...

Full description

Bibliographic Details
Main Authors: José Luis Górriz, María José Soler, Juan F. Navarro-González, Clara García-Carro, María Jesús Puchades, Luis D’Marco, Alberto Martínez Castelao, Beatriz Fernández-Fernández, Alberto Ortiz, Carmen Górriz-Zambrano, Jorge Navarro-Pérez, Juan José Gorgojo-Martinez
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Journal of Clinical Medicine
Subjects:
chronic kidney disease
diabetic kidney disease
GLP-1
Online Access:https://www.mdpi.com/2077-0383/9/4/947

Internet

https://www.mdpi.com/2077-0383/9/4/947

Similar Items